Lansoprazole Pellets manufacturers & suppliers

Lansoprazole Pellets

Form: Pellets

Strength: 15 mg and 30 mg

Reference Brands: Prevacid

Category: Active Pharmaceutical Ingredient

Lansoprazole pellets API is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality following GMP standards. In the US, FDA approval involves validation, safety testing, and clinical validation. In the EU, CE marking certifies compliance with MDR standards. These formulations undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees access to high-quality lansoprazole pellet formulations, supporting effective treatment of GERD, ulcers, and gastritis worldwide, promoting gastrointestinal health and well-being.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Zinc Sulfate Powder

Strength: Typically supplied as high-purity powder or crystals

Form: Powder/Granules or lumps

Reference Brands: Generic zinc sulfate

View Details
Clotrimazole Granules Or Pastes

Strength: High-purity API

Form: Granules/ Paste

Reference Brands: Generic clotrimazole APIs

View Details
Clotrimazole Granules Or Pastes

Strength: High-purity API

Form: Granules/ Paste

Reference Brands: Generic clotrimazole APIs

View Details
Mupirocin Granules

Strength: Pharmaceutical-grade powders for formulation into topical creams, ointments, or injectable products

Form: Granules/powder

Reference Brands: Generic mupirocin API

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.